Evidence map›Paper›PMID 24777183›Full record

ReviewBone marrow transplantation2014

Challenges and opportunities for HSCT outcome registries: perspective from international HSCT registries experts.

M Aljurf, J D Rizzo, M Mohty, F Hussain, A Madrigal, M C Pasquini, J Passweg, N Chaudhri, A Ghavamzadeh, H E Solh and 6 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Bone marrow transplantation, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. International Comparison of Thalassemia Registries: Challenges and Opportunities.Acta informatica medica : AIM : journal of the Society for Medical Informatics of Bosnia & Herzegovina : casopis Drustva za medicinsku informatiku BiH · 2019
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

M AljurfOncology Center, King Faisal Specialist Hospital and Research Centre, Riyadh, Kingdom of Saudi Arabia.
J D RizzoCenter for International Blood and Marrow Transplant Research, Milwaukee, WI, USA.
M MohtyHematology Department, Saint-Antoine Hospital, Paris, France.
F HussainOncology Center, King Faisal Specialist Hospital and Research Centre, Riyadh, Kingdom of Saudi Arabia.
A MadrigalThe Royal Free and University College Medical School, London, UK.
M C PasquiniCenter for International Blood and Marrow Transplant Research, Milwaukee, WI, USA.
J PasswegUniversity of Leipzig, Leipzig, Germany.
N ChaudhriOncology Center, King Faisal Specialist Hospital and Research Centre, Riyadh, Kingdom of Saudi Arabia.
A GhavamzadehTehran University of Medical Sciences, Hematology, Oncology and SCT Research Center, Tehran, Iran.
H E SolhOncology Center, King Faisal Specialist Hospital and Research Centre, Riyadh, Kingdom of Saudi Arabia.
Y AtsutaNagoya University Graduate School of Medicine, Nagoya, Japan.
J SzerThe Royal Melbourne Hospital, Parkville, Australia.
Y KoderaAichi Medical University School of Medicine, Aichi, Japan.
D NiederweiserUniversity of Leipzig, Leipzig, Germany.
A GratwohlUniversity Hospital of Basel, Basel, Switzerland.
M M HorowitzCenter for International Blood and Marrow Transplant Research, Milwaukee, WI, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patient registries, frequently referred to as outcome registries, are 'organized systems' that use observational study methods to collect uniform data. Registries are used to evaluate specified outcomes for a population defined by a particular disease, condition or exposure that serves one or more predetermined scientific, clinical or policy purposes. Outcome registries were established very early in the development of hematopoietic SCT (HSCT). Currently, myriads of national and international HSCT registries collect information about HSCT activities and outcomes. These registries have contributed significantly to determining trends, patterns, treatment practices and outcomes. There are many different HSCT registries, each with different aims and goals; some are led by professional organizations, others by government authorities, health care providers or third parties. Some registries simply assess activity and others study outcomes. These registries are complementary and are gradually developing interoperability with each other to expand future collaborative research activities. A key development in the last few years was the incorporation of recommendations into the World Health Organization guiding principles on cell, tissue and organ transplantation. The data collection and analysis should be an integral part of therapy and an obligation rather than a choice for transplant programs. This article examines challenges in ensuring data quality and functions of outcome registries, using HSCT registries as an example. It applies to all HSCT-related data, but is predominantly focused on HSCT registries of professional organizations.

Indexed as

Hematopoietic Stem Cell TransplantationRegistriesHumansMulticenter Studies as Topic

Identifiers

PMID24777183

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.